The serum bile acid composition of breast cancer and benign breast disease patients is different; specifically, breast cancer patients had higher serum chenodeoxycholic acid levels and lower dihydroxy tauro-conjugated BA (Tdi-1) and sulfated dihydroxy glyco-conjugated bile acids (Gdi-S-1) [260]. Here, GDI1 is linked to breast cancer.